{
    "nct_id": "NCT04640025",
    "official_title": "A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib (INCB039110)",
    "inclusion_criteria": "* Currently enrolled and receiving treatment in an Incyte-sponsored itacitinib (INCB39110)-based clinical study (parent Protocol).\n* Currently tolerating treatment as defined by the parent Protocol.\n* Currently receiving clinical benefit from itacitinib-based treatment, as determined by the investigator.\n* Has demonstrated compliance, as assessed by the investigator, with the parent protocol requirements.\n* Willingness and ability to comply with scheduled visits, treatment plans, and any other study procedures indicated in this Protocol.\n* Willingness to avoid pregnancy or fathering children..\n* Ability to comprehend and willingness to sign an ICF.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Able to access itacitinib therapy commercially.\n* Participants with an uncontrolled intercurrent illness or any concurrent condition that, in the investigator's opinion, would jeopardize the safety of the participant or compliance with the Protocol.\n* Pregnant or breastfeeding women.",
    "miscellaneous_criteria": ""
}